menu
    • menu

    Company profile for Mereo BioPharma Group

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mereo is a UK-based specialty biopharma company established to address the R&D and financial challenges faced by an increasing number of large pharma and biotech companies. Mereo’s business model brings clear benefits to these companies, to investors, and to patients. Large pharmaceutical companies’ pipelines have a significant number of promising new product candidates, but increasing P&L pressures and competition for R&D...
    Mereo is a UK-based specialty biopharma company established to address the R&D and financial challenges faced by an increasing number of large pharma and biotech companies. Mereo’s business model brings clear benefits to these companies, to investors, and to patients. Large pharmaceutical companies’ pipelines have a significant number of promising new product candidates, but increasing P&L pressures and competition for R&D resources combined with strategic changes of direction mean that some of these candidates are not advanced.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mereo BioPharma Groupunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    1 Cavendish Place London W1G 0QF
    Telephone
    Telephone
    +44 (0)333 023 7300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mereobiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Investors Sue Mereo BioPharma for Securities Violations
    Investors Sue Mereo BioPharma for Securities Violations

    30 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mereo-biopharma-group-plc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--mreo-302728373.html

    PR NEWSWIRE
    30 Mar 2026
    Share Share
    Mereo Biopharma Reveals 2025 Financials And Corporate Highlights
    Mereo Biopharma Reveals 2025 Financials And Corporate Highlights

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258998/0/en/Mereo-BioPharma-Reports-Full-Year-2025-Financial-Results-and-Provides-Corporate-Highlights.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Mereo Biopharma Provides Corporate Update
    Mereo Biopharma Provides Corporate Update

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216842/0/en/Mereo-BioPharma-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Mereo Biopharma Reveals Setrusumab (UX143) Phase 3 Results
    Mereo Biopharma Reveals Setrusumab (UX143) Phase 3 Results

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210923/0/en/Mereo-BioPharma-Announces-Phase-3-ORBIT-and-COSMIC-Results-for-Setrusumab-UX143-in-Osteogenesis-Imperfecta.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Mereo Biopharma Reveals Q3 2025 Financials And Corporate
    Mereo Biopharma Reveals Q3 2025 Financials And Corporate

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185063/0/en/Mereo-BioPharma-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Highlights.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Mereo BioPharma Q2 2025 Financial Results & Corporate Highlights
    Mereo BioPharma Q2 2025 Financial Results & Corporate Highlights

    12 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/12/3131598/0/en/Mereo-BioPharma-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Highlights.html

    GLOBENEWSWIRE
    12 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search